Arié Figer

19.9k citations
90 papers · 15.7k · 6 hit papers · h-index 35

Impact in

  • Oncology top 0.1%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments
  • Hepatology top 0.2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 22
    • Colorectal Cancer Screening and Detection 10
    • Pancreatic and Hepatic Oncology Research 9
    • Genetic factors in colorectal cancer 18

Arié Figer

88 papers receiving 15.0k citations

Arié Figer's Hit Papers

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study 2008 · 2.5k citations
2.5k0+8+17Years since publication10002.0k3.0k

Peers

Arié Figer
Comparison fields: 5 of 132
  • Oncology 10.2k
  • Hepatology 2.4k
  • Cancer Research 1.6k
  • Pulmonary and Respiratory Medicine 2.6k
  • Pathology and Forensic Medicine 1.4k
Replace Eduardo Díaz‐Rubio with:
Eduardo Díaz‐Rubio Spain
Corrado Boni Italy
Howard S. Höchster United States
Steven R. Alberts United States
Christophe Louvet France
Per Pfeiffer Denmark
Jim Cassidy United Kingdom
Fernando Rivera Spain
Alberto Felice Sobrero Italy
George E. Pentheroudakis Greece
Arié Figer relative to Eduardo Díaz‐Rubio Spain Eduardo Díaz‐Rubio's profile →
Citations per field
00.5×1.5×
Eduardo Díaz‐Rubio · 1×
Citations per year

Countries citing papers authored by Arié Figer

Since Specialization
Citations

This map shows the geographic impact of Arié Figer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arié Figer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arié Figer more than expected).

Fields of papers citing papers by Arié Figer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arié Figer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arié Figer. The network helps show where Arié Figer may publish in the future.

Co-authors

The 25 scholars most cited alongside Arié Figer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arié Figer Line = papers co-authored together Arié Figer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
Hit paper breakdown →
20003254
2
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Hit paper breakdown →
20073124
3
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Hit paper breakdown →
20082480
4
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Hit paper breakdown →
20061031
5
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Hit paper breakdown →
2008724
6
OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study
Hit paper breakdown →
2006660
7 2007499
8 2004450
9 2008258
10 2006235
11 2004203
12 2008198
13 2011189
14 2002176
15 2007127
16 2002116
17 2007113
18 1987109
19 2006103
20
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis.
201188

About Arié Figer

Arié Figer is a scholar working on Oncology, Pathology and Forensic Medicine, Obstetrics and Gynecology, Genetics and Cancer Research, having authored 90 papers that have together received 15.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Genetic factors in colorectal cancer (18 papers), Colorectal Cancer Screening and Detection (10 papers), Endometrial and Cervical Cancer Treatments (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Estrogen and related hormone effects (8 papers), Cancer Genomics and Diagnostics (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (10.2k citations), Hepatology (2.4k citations), Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Pathology and Forensic Medicine (1.4k citations). Arié Figer has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Jim Cassidy, Leonard B. Saltz, Werner Scheithauer, Eduardo Díaz‐Rubio, Fernando Rivera, Stephen John Clarke, Sheryl L. Koski, Florin Sirzén, Mikhail Lichinitser and Tsai‐Shen Yang. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Gynecologic Oncology, British Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact